Ken Griffin Sensus Healthcare, Inc. Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Sensus Healthcare, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 2,200 shares of SRTS stock, worth $11,726. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,200Holding current value
$11,726% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding SRTS
# of Institutions
48Shares Held
2.47MCall Options Held
2.2KPut Options Held
3K-
Vanguard Group Inc Valley Forge, PA779KShares$4.15 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny291KShares$1.55 Million0.0% of portfolio
-
Perritt Capital Management Inc Chicago, IL131KShares$696,0230.28% of portfolio
-
Geode Capital Management, LLC Boston, MA128KShares$680,1980.0% of portfolio
-
Invenire Partners, LP Ridgefield, CT119KShares$633,561100.0% of portfolio
About Sensus Healthcare, Inc.
- Ticker SRTS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 16,556,000
- Market Cap $88.2M
- Description
- Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provide...